At Halcyon,
industry shaking technology
is in our genes.
![](https://lipidbond.com/wp-content/uploads/2021/08/Halcyon-Technology-Holdings-Benchmark-CBD-Hemp-CBD-Processing-scaled.jpg)
Revolutionary LipidBond™ Technology
Halcyon Technology Holdings has introduced Lipidbond™, a patented fusion process that can bond any botanical with any lipid at the molecular level. LipidBond has far reaching potential in a variety of industries, offering a cost-effective, environmentally friendly way to produce products.
![](https://lipidbond.com/wp-content/uploads/2023/06/LipidBond-Applications-v2.png)
![](https://lipidbond.com/wp-content/uploads/2021/10/About-Us-Halcyon-Graphic.png)
Our core values drive our success
With our technology we aim to make a positive impact in as many industries as possible. Providing a superior product at an accessible price has always been the lens in which we view our business through.
Bringing the best minds together
Our team is comprised of world-class business leaders in product formulation, healthcare, chemical analysis, agriculture, branding, product development, finance and hospitality.
![](https://lipidbond.com/wp-content/uploads/2021/10/Halcyon-Technology-Holdings-Icon-dashed-graphic-1000x1000-1.png)
![](https://lipidbond.com/wp-content/uploads/2021/10/3D-Block-Halcyon-Technology-Holdings-Companies-v2.png)
Transforming industries with our
Halcyon has developed brands and partnered with companies that are pursuing ethical success and innovation.
Looking to connect?
![](https://lipidbond.com/wp-content/uploads/2021/10/Halcyon-Octagon.png)
Company News
Following the reasoning in the Pharmanex case, CBD isolate may be subject to the Drug Exclusion Rule, but processed hemp, such as full- and broad-spectrum hemp extracts, may not.
he past several years have seen extensive debate about the legal status of cannabidiol (CBD). Is it legal? Was it ever a controlled substance? How is it regulated?
Leading researchers in the USA will check the effectiveness of whole-plant versus single-extract CBD under a $9 million project aimed at enlightening consumers and doctors.